Interpace Biosciences, Inc. IDXG
5.35 USD -0.37 (-6.47%)
At closeOct 30, 2026, 4:00 PM EDT
5.35 Day range 5.35
0.806 52-week range 7.80
- YTD
- +334.96%
- 1 year
- +424.51%
Analyst view
Consensus: buy
Buy
Price target (mean) 8.43 +57.6% upside
Now 5.35
- Target (low)
- 6.00
- Target (mean)
- 8.43
- Target (high)
- 12.00
Ratings (0m) 1 1 buy · 0 hold · 0 sell
- Strong buy0
- Buy1
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 1
- 1 month ago 4
- 2 months ago 4
- 3 months ago 1
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -1.15 | -1.35 – -0.77 | -2.95 | +61.0% | 8.85M | +117.2% | 3 |
| Next quarter | -1.05 | -1.18 – -0.93 | -2.32 | +54.7% | 10.28M | 0.0% | 2 |
| Current year | -6.02 | -6.62 – -5.71 | -7.25 | +17.0% | 31.43M | +30.5% | 3 |
| Next year | -1.94 | -3.61 – -0.60 | -6.02 | +67.8% | 45.55M | +44.9% | 3 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jan 24, 2021 | HC Wainwright & Co. | Maintained | — | Buy |
| Oct 21, 2020 | HC Wainwright & Co. | Maintained | — | Buy |
| Jun 25, 2020 | HC Wainwright & Co. | Maintained | — | Buy |
| Apr 22, 2020 | H.C. Wainwright | Maintained | — | Buy |
| Apr 14, 2020 | Janney Capital | Initiated | — | Buy |
| Jan 15, 2020 | Oppenheimer | Maintained | — | Outperform |
